MetaADEDB 2.0 @ LMMD
telotristat ethyl
(MDSQOJYHHZBZKA-GBXCKJPGSA-N)
Structure
SMILES
CCOC(=O)[C@H](Cc1ccc(cc1)c1cc(nc(n1)N)O[C@@H](C(F)(F)F)c1ccc(cc1n1ccc(n1)C)Cl)N
Type(s)
Approved; Investigational
Molecular Formula:
C27H26ClF3N6O3
Molecular Weight:
574.982
Log P:
6.2701
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
2
TPSA:
131.17
CAS Number(s):
1033805-22-9
Synonym(s)
1.
telotristat ethyl
External Link(s)
MeSHC000621725
PubChem Compound25181577
25025298
CHEMBLCHEMBL2105695
DrugBankDB12095
DrugCentral5214
IUPHAR/BPS Guide to PHARMACOLOGY9490
KEGGdr:D09974
Therapeutic Target DatabaseD0RE6T
ZINC43205655
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ConstipationFAERS: 163US FAERS
2NauseaFAERS: 139
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Abdominal PainFAERS: 137US FAERS
4FlatulenceFAERS: 103
Canada Vigilance: 1
Canada Vigilance
US FAERS
5Drug ineffectiveFAERS: 92
Canada Vigilance: 1
Canada Vigilance
US FAERS
6FatigueFAERS: 88US FAERS
7HeadacheFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
8MalaiseFAERS: 70US FAERS
9FlushingFAERS: 66US FAERS
10AstheniaFAERS: 56US FAERS
11Product dose omissionFAERS: 46US FAERS
12VomitingFAERS: 46US FAERS
13DehydrationFAERS: 32US FAERS
14DizzinessFAERS: 31US FAERS
15Drug dose omissionFAERS: 29US FAERS
16Abdominal discomfortFAERS: 27US FAERS
17Back PainFAERS: 27US FAERS
18Weight decreasedFAERS: 27US FAERS
19Blood glucose increasedFAERS: 25US FAERS
20Blood potassium decreasedFAERS: 22US FAERS
21Chest PainFAERS: 22US FAERS
22Disease ProgressionFAERS: 22US FAERS
23Hospice CareFAERS: 19US FAERS
24PainFAERS: 19US FAERS
25Peripheral swellingFAERS: 18US FAERS
26Urinary tract infectionFAERS: 18US FAERS
27NasopharyngitisFAERS: 15US FAERS
28PruritusFAERS: 13US FAERS
29Blood magnesium decreasedFAERS: 12US FAERS
30AnxietyFAERS: 11US FAERS
31Blood alkaline phosphatase increasedFAERS: 11US FAERS
32Blood chromogranin A increasedFAERS: 11US FAERS
33Feeling abnormalFAERS: 11US FAERS
34SomnolenceFAERS: 10US FAERS
35InfluenzaFAERS: 9US FAERS
36Oropharyngeal painFAERS: 9US FAERS
37ArthralgiaFAERS: 8US FAERS
38Blood albumin decreasedFAERS: 8US FAERS
39HypotensionFAERS: 8US FAERS
40Intestinal ObstructionFAERS: 8US FAERS
41PneumoniaFAERS: 8US FAERS
42Adverse eventFAERS: 7US FAERS
43Lymphocyte count decreasedFAERS: 7US FAERS
44PalpitationsFAERS: 7US FAERS
45Anorectal discomfortFAERS: 6US FAERS
46AscitesFAERS: 6US FAERS
47Blood urea increasedFAERS: 6US FAERS
48ChillsFAERS: 6US FAERS
49DysgeusiaFAERS: 6US FAERS
50Intra-abdominal fluid collectionFAERS: 6US FAERS
51Joint swellingFAERS: 6US FAERS
52Emotional distressFAERS: 5US FAERS
53ErythemaFAERS: 5US FAERS
54GoutFAERS: 5US FAERS
55HypersensitivityFAERS: 5US FAERS
56Protein total decreasedFAERS: 5US FAERS
57StressFAERS: 5US FAERS
58SyncopeFAERS: 5US FAERS
59White blood cell count decreasedFAERS: 5US FAERS
60ArthritisFAERS: 4US FAERS
61Blood chloride decreasedFAERS: 4US FAERS
62Blood creatinine decreasedFAERS: 4US FAERS
63Blood iron decreasedFAERS: 4US FAERS
64Blood potassium increasedFAERS: 4US FAERS
65Cancer PainFAERS: 4US FAERS
66Cataract operationFAERS: 4US FAERS
67CellulitisFAERS: 4US FAERS
68Chest discomfortFAERS: 4US FAERS
69CholelithiasisFAERS: 4US FAERS
70CryingFAERS: 4US FAERS
71DisorientationFAERS: 4US FAERS
72Dry skinFAERS: 4US FAERS
73DysphoniaFAERS: 4US FAERS
74EpistaxisFAERS: 4US FAERS
75Gastrointestinal PainFAERS: 4US FAERS
76Intentional product misuseFAERS: 4US FAERS
77Limb discomfortFAERS: 4US FAERS
78LymphadenopathyFAERS: 4US FAERS
79NervousnessFAERS: 4US FAERS
80Product use in unapproved indicationFAERS: 4US FAERS
81VertigoFAERS: 4US FAERS
82AgeusiaFAERS: 3US FAERS
83AgitationFAERS: 3US FAERS
84Blood creatinine increasedFAERS: 3US FAERS
85Cerebrovascular accidentFAERS: 3US FAERS
86ChemotherapyFAERS: 3US FAERS
87EructationFAERS: 3US FAERS
88Flank PainFAERS: 3US FAERS
89General physical health deteriorationFAERS: 3US FAERS
90HepatomegalyFAERS: 3US FAERS
91HypophagiaFAERS: 3US FAERS
92Limb injuryFAERS: 3US FAERS
93Lip swellingFAERS: 3US FAERS
94MetastasisFAERS: 3US FAERS
95Neck PainFAERS: 3US FAERS
96Night sweatsFAERS: 3US FAERS
97Pericardial effusionFAERS: 3US FAERS
98Pulmonary EmbolismFAERS: 3US FAERS
99RadioembolisationFAERS: 3US FAERS
100Restless Legs SyndromeFAERS: 3US FAERS
101SwellingFAERS: 3US FAERS
102ThrombosisFAERS: 3US FAERS
103TinnitusFAERS: 3US FAERS
104Tooth ExtractionFAERS: 3US FAERS
1055-hydroxyindolacetic acid in urine increasedFAERS: 2US FAERS
1065-hydroxyindolacetic acid increasedFAERS: 2US FAERS
107Abdominal cavity drainageFAERS: 2US FAERS
108AcneFAERS: 2US FAERS
109Acute kidney injuryFAERS: 2US FAERS
110Alanine Aminotransferase IncreasedFAERS: 2US FAERS
111AlopeciaFAERS: 2US FAERS
112Ammonia increasedFAERS: 2US FAERS
113Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
114AsthmaFAERS: 2US FAERS
115Bladder neoplasm surgeryFAERS: 2US FAERS
116Blood chloride increasedFAERS: 2US FAERS
117Blood creatine increasedFAERS: 2US FAERS
118Blood sodium decreasedFAERS: 2US FAERS
119Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
120Blood urine presentFAERS: 2US FAERS
121BronchitisFAERS: 2US FAERS
122Burning sensationFAERS: 2US FAERS
123Complication associated with deviceFAERS: 2US FAERS
124Creatinine renal clearance decreasedFAERS: 2US FAERS
125CystitisFAERS: 2US FAERS
126Depressed moodFAERS: 2US FAERS
127Device related infectionFAERS: 2US FAERS
128Diabetes mellitus inadequate controlFAERS: 2US FAERS
129DiscomfortFAERS: 2US FAERS
130DyspepsiaFAERS: 2US FAERS
131Eating disorder symptomFAERS: 2US FAERS
132EczemaFAERS: 2US FAERS
133Electrolyte imbalanceFAERS: 2US FAERS
134Eye InfectionFAERS: 2US FAERS
135Food PoisoningFAERS: 2US FAERS
136Gastrointestinal motility disorderFAERS: 2US FAERS
137Gastrointestinal sounds abnormalFAERS: 2US FAERS
138Hepatic InfectionFAERS: 2US FAERS
139HungerFAERS: 2US FAERS
140HypersomniaFAERS: 2US FAERS
141Incorrect dose administeredFAERS: 2US FAERS
142Joint injuryFAERS: 2US FAERS
143Laser TherapyFAERS: 2US FAERS
144LethargyFAERS: 2US FAERS
145LeukocytosisFAERS: 2US FAERS
146Malignant neoplasm progressionFAERS: 2US FAERS
147Monocyte count increasedFAERS: 2US FAERS
148Muscle strainFAERS: 2US FAERS
149Musculoskeletal PainFAERS: 2US FAERS
150Musculoskeletal chest painFAERS: 2US FAERS
151MyalgiaFAERS: 2US FAERS
152Myocardial InfarctionFAERS: 2US FAERS
153N-terminal prohormone brain natriuretic peptide increasedFAERS: 2US FAERS
154NephrolithiasisFAERS: 2US FAERS
155Neutrophil count decreasedFAERS: 2US FAERS
156Oncologic complicationFAERS: 2US FAERS
157OverdoseFAERS: 2US FAERS
158Pancreastatin increasedFAERS: 2US FAERS
159Pancreatic carcinomaFAERS: 2US FAERS
160ParacentesisFAERS: 2US FAERS
161Pelvic PainFAERS: 2US FAERS
162Post procedural constipationFAERS: 2US FAERS
163Rash erythematousFAERS: 2US FAERS
164Rectal dischargeFAERS: 2US FAERS
165Reflux gastritisFAERS: 2US FAERS
166RegurgitationFAERS: 2US FAERS
167SepsisFAERS: 2US FAERS
168SneezingFAERS: 2US FAERS
169StomatitisFAERS: 2US FAERS
170Subcutaneous AbscessFAERS: 2US FAERS
171Suprapubic painFAERS: 2US FAERS
172Therapeutic procedureFAERS: 2US FAERS
173ThrombocytopeniaFAERS: 2US FAERS
174TremorFAERS: 2US FAERS
175UrticariaFAERS: 2US FAERS
176Visual ImpairmentFAERS: 2US FAERS
177WheezingFAERS: 2US FAERS
178Wrong doseFAERS: 2US FAERS
179diagnostic procedureFAERS: 2US FAERS
1805-hydroxyindolacetic acid decreasedFAERS: 1US FAERS
181Abdominal tendernessFAERS: 1US FAERS
182Abnormal sleep-related eventFAERS: 1US FAERS
183AbscessFAERS: 1US FAERS
184Alanine aminotransferase decreasedFAERS: 1US FAERS
185Anal abscessFAERS: 1US FAERS
186Anaphylactic shockFAERS: 1US FAERS
187AngerFAERS: 1US FAERS
188Arteriovenous fistula occlusionFAERS: 1US FAERS
189Arthropod stingFAERS: 1US FAERS
190Atrial FibrillationFAERS: 1US FAERS
191AversionFAERS: 1US FAERS
192Basophil percentage decreasedFAERS: 1US FAERS
193BedriddenFAERS: 1US FAERS
194Biliary ColicFAERS: 1US FAERS
195Bladder NeoplasmFAERS: 1US FAERS
196Blood bilirubin decreasedFAERS: 1US FAERS
197Blood count abnormalFAERS: 1US FAERS
198Blood electrolytes decreasedFAERS: 1US FAERS
199Blood gastrin increasedFAERS: 1US FAERS
200Blood glucose decreasedFAERS: 1US FAERS
201Blood pressure fluctuationFAERS: 1US FAERS
202Blood triglycerides increasedFAERS: 1US FAERS
203Bone painFAERS: 1US FAERS
204Bowel movement irregularityFAERS: 1US FAERS
205Breakthrough PainFAERS: 1US FAERS
206Breast cancer recurrentFAERS: 1US FAERS
207Breast tendernessFAERS: 1US FAERS
208BronchospasmFAERS: 1US FAERS
209Carbon dioxide decreasedFAERS: 1US FAERS
210Carcinoid Heart DiseaseFAERS: 1US FAERS
211Carcinoid crisisFAERS: 1US FAERS
212Cholecystitis infectiveFAERS: 1US FAERS
213Chronic gastritisFAERS: 1US FAERS
214Clostridium difficile infectionFAERS: 1US FAERS
215Cold sweatFAERS: 1US FAERS
216ColitisFAERS: 1US FAERS
217Contrast media allergyFAERS: 1US FAERS
218Contrast media toxicityFAERS: 1US FAERS
219Corneal implantFAERS: 1US FAERS
220Device occlusionFAERS: 1US FAERS
221Disease complicationFAERS: 1US FAERS
222DroolingFAERS: 1US FAERS
223Drug administration errorFAERS: 1US FAERS
224Drug effect incompleteFAERS: 1US FAERS
225DysuriaFAERS: 1US FAERS
226EmbolismFAERS: 1US FAERS
227Emergency CareFAERS: 1US FAERS
228Emotional disorderFAERS: 1US FAERS
229Endodontic procedureFAERS: 1US FAERS
230EnteritisFAERS: 1US FAERS
231Eosinophil percentage decreasedFAERS: 1US FAERS
232Exposure via fatherFAERS: 1US FAERS
233Facial paralysisFAERS: 1US FAERS
234Failure to ThriveFAERS: 1US FAERS
235Fibrin D dimer increasedFAERS: 1US FAERS
236Full blood count decreasedFAERS: 1US FAERS
237Gait inabilityFAERS: 1US FAERS
238Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
239Gastrointestinal infectionFAERS: 1US FAERS
240General physical condition abnormalFAERS: 1US FAERS
241General symptomFAERS: 1US FAERS
242Gluten sensitivityFAERS: 1US FAERS
243Hormone level abnormalFAERS: 1US FAERS
244HypokinesiaFAERS: 1US FAERS
245HypothyroidismFAERS: 1US FAERS
246Impaired driving abilityFAERS: 1US FAERS
247Implantable defibrillator insertionFAERS: 1US FAERS
248Incision site painFAERS: 1US FAERS
249Incisional herniaFAERS: 1US FAERS
250Incorrect route of product administrationFAERS: 1US FAERS
251Increased tendency to bruiseFAERS: 1US FAERS
252Increased upper airway secretionFAERS: 1US FAERS
253InfectionFAERS: 1US FAERS
254Infectious colitisFAERS: 1US FAERS
255Infusion site infectionFAERS: 1US FAERS
256Injection site massFAERS: 1US FAERS
257Intestinal metastasisFAERS: 1US FAERS
258Intestinal resectionFAERS: 1US FAERS
259Joint stiffnessFAERS: 1US FAERS
260KeratomileusisFAERS: 1US FAERS
261Lip exfoliationFAERS: 1US FAERS
262Liver AbscessFAERS: 1US FAERS
263Liver ablationFAERS: 1US FAERS
264Liver scan abnormalFAERS: 1US FAERS
265Living in residential institutionFAERS: 1US FAERS
266Loss of personal independence in daily activitiesFAERS: 1US FAERS
267Lung neoplasm surgeryFAERS: 1US FAERS
268Lymphatic system neoplasmFAERS: 1US FAERS
269Lymphocyte percentage decreasedFAERS: 1US FAERS
270MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
271MalnutritionFAERS: 1US FAERS
272MastectomyFAERS: 1US FAERS
273Memory impairmentFAERS: 1US FAERS
274Mineral supplementationFAERS: 1US FAERS
275Monocyte percentage decreasedFAERS: 1US FAERS
276Mood swingsFAERS: 1US FAERS
277Musculoskeletal discomfortFAERS: 1US FAERS
278NocturiaFAERS: 1US FAERS
279ObstructionFAERS: 1US FAERS
280Pain of skinFAERS: 1US FAERS
281Palliative CareFAERS: 1US FAERS
282Pancreatic PseudocystFAERS: 1US FAERS
283Pancreatic operationFAERS: 1US FAERS
284Parenteral NutritionFAERS: 1US FAERS
285PneumothoraxFAERS: 1US FAERS
286Portal shunt procedureFAERS: 1US FAERS
287Pre-existing condition improvedFAERS: 1US FAERS
288PregnancyFAERS: 1US FAERS
289Prerenal failureFAERS: 1US FAERS
290Product supply issueFAERS: 1US FAERS
291Product use issueFAERS: 1US FAERS
292Productive CoughFAERS: 1US FAERS
293Protein DeficiencyFAERS: 1US FAERS
294Pulmonary FibrosisFAERS: 1US FAERS
295Radiation injuryFAERS: 1US FAERS
296Renal ColicFAERS: 1US FAERS
297RetchingFAERS: 1US FAERS
298Scarlet FeverFAERS: 1US FAERS
299Secretion dischargeFAERS: 1US FAERS
300Sinus headacheFAERS: 1US FAERS
301Skin lesionFAERS: 1US FAERS
302Skin neoplasm excisionFAERS: 1US FAERS
303Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
304SplenomegalyFAERS: 1US FAERS
305SpondylitisFAERS: 1US FAERS
306TachycardiaFAERS: 1US FAERS
307Temporal ArteritisFAERS: 1US FAERS
308Therapeutic product effect variableFAERS: 1US FAERS
309Throat irritationFAERS: 1US FAERS
310Thyroid hormones increasedFAERS: 1US FAERS
311ToothacheFAERS: 1US FAERS
312Umbilical herniaFAERS: 1US FAERS
313Urinary RetentionFAERS: 1US FAERS
314Urinary tract obstructionFAERS: 1US FAERS
315Urine output increasedFAERS: 1US FAERS
316Wrong technique in product usage processFAERS: 1US FAERS
317colonoscopyFAERS: 1US FAERS
318jaundiceFAERS: 1US FAERS
319Inappropriate schedule of product administrationCanada Vigilance: 1Canada Vigilance
320Skin reactionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.